Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · IEX Real-Time Price · USD
5.25
-0.33 (-5.91%)
Mar 28, 2024, 3:52 PM EDT - Market open

Puma Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2007
Revenue
235.64228.03253.16225.11272.26250.9927.69000
Upgrade
Revenue Growth (YoY)
3.34%-9.92%12.46%-17.32%8.47%806.60%----
Upgrade
Cost of Revenue
62.6855.0963.739.3736.8234.625.57000
Upgrade
Gross Profit
172.96172.94189.45185.74235.45216.3722.11000
Upgrade
Selling, General & Admin
89.9389.98116.29118.49141.64146.17106.6953.831.8119.36
Upgrade
Research & Development
50.3852.2471.8797.65132.85164.85207.81222.8208.47122.92
Upgrade
Other Operating Expenses
0700000000
Upgrade
Operating Expenses
140.32149.22188.16216.14274.49311.03314.5276.6240.28142.28
Upgrade
Operating Income
32.6423.721.29-30.4-39.05-94.66-292.39-276.6-240.28-142.28
Upgrade
Interest Expense / Income
13.3311.5912.8114.0515.0210.990.72000
Upgrade
Other Expense / Income
-3.3611.6717.2915.3421.487.92-1.16-0.59-1-0.31
Upgrade
Pretax Income
22.670.46-28.8-59.79-75.54-113.56-291.96-276.01-239.28-141.97
Upgrade
Income Tax
1.080.460.320.210.050.020000
Upgrade
Net Income
21.590-29.13-60-75.6-113.58-291.96-276.01-239.28-141.97
Upgrade
Net Income Growth
1079450.00%---------
Upgrade
Shares Outstanding (Basic)
47454140393837333230
Upgrade
Shares Outstanding (Diluted)
48454140393837333230
Upgrade
Shares Change
5.83%10.56%2.69%2.08%2.18%2.08%11.64%3.64%7.05%4.58%
Upgrade
EPS (Basic)
0.46--0.72-1.52-1.95-2.99-7.85-8.29-7.45-4.73
Upgrade
EPS (Diluted)
0.45--0.72-1.52-1.95-2.99-7.85-8.29-7.45-4.73
Upgrade
Free Cash Flow
26.87-15.8320.650.7322.07-24.71-172.9-148.97-155.65-78.5
Upgrade
Free Cash Flow Per Share
0.57-0.350.510.020.57-0.65-4.65-4.47-4.84-2.62
Upgrade
Gross Margin
73.40%75.84%74.84%82.51%86.48%86.21%79.87%---
Upgrade
Operating Margin
13.85%10.40%0.51%-13.51%-14.34%-37.71%-1056.13%---
Upgrade
Profit Margin
9.16%0.00%-11.51%-26.65%-27.77%-45.25%-1054.56%---
Upgrade
Free Cash Flow Margin
11.40%-6.94%8.16%0.32%8.11%-9.85%-624.53%---
Upgrade
Effective Tax Rate
4.78%99.56%--------
Upgrade
EBITDA
47.5221.89-4.69-35.71-52.45-95.19-288.42-274.86-238.51-141.34
Upgrade
EBITDA Margin
20.17%9.60%-1.85%-15.86%-19.26%-37.93%-1041.81%---
Upgrade
Depreciation & Amortization
11.529.8411.3110.038.087.382.811.150.780.63
Upgrade
EBIT
3612.05-16-45.74-60.52-102.57-291.24-276.01-239.28-141.97
Upgrade
EBIT Margin
15.28%5.28%-6.32%-20.32%-22.23%-40.87%-1051.96%---
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).